Human ocular cell and tissue platforms

  • 2D ocular cell assays (corneal, conjunctival, RPE, retinal endothelial/pericyte support cells)
  • Primary-cell and iPSC-derived ocular cell platforms (e.g., iPSC-RPE for disease-relevant phenotypes)
  • 3D reconstructed corneal microtissues / organotypic models for efficacy and safety screening
  • Ophthalmic organoid / advanced 3D platforms (retinal organoid workflows as a premium offering)

Barrier function and permeation

  • Corneal penetration / permeability (Transwell, TEER, tight-junction imaging) using corneal epithelial models
  • Outer blood–retina barrier (oBRB) models (RPE–endothelial bilayer on inserts; FITC-dextran permeability)

Efficacy proof-of-concept in key ophthalmology areas

  • Retinal degeneration / AMD biology: RPE stress, complement/oxidative stress, phagocytosis, barrier disruption phenotypes
  • Dry eye / ocular surface inflammation: epithelial cytokine panels, wound-healing, mucin markers, irritation pathways
  • Fibrosis and scarring: conjunctival/corneal fibroblast activation (α-SMA, collagen), TGF-β driven models
  • Angiogenesis/vascular dysfunction: endothelial tube formation, VEGF signalling, permeability assays (incl. oBRB)

Mechanism-of-action and biomarker services

  • Target engagement / pathway mapping (phospho-signalling, cytokines, transcript panels)
  • Biomarker strategy: inflammatory, fibrotic, vascular and neuronal/retinal stress marker panels (fit-for-purpose)

Safety and tolerability (in vitro ocular)

  • Ocular irritation/cytotoxicity screening in corneal microtissues and ocular cell lines (viability, LDH, histology-style endpoints)
  • Inflammatory risk profiling (IL-6/IL-8/TNF etc.) in ocular surface models
  • Off-target liability using barrier disruption + recovery readouts

Functional readouts (high differentiation / premium)

  • Cell-based potency assays concept (especially relevant for biologics/gene therapies; framed as custom potency assay development)

Custom model and assay development

  • Bespoke assay development + validation (fit-for-purpose, repeatability, transfer packs)
  • Comparability studies (formulation A vs B, innovator vs generic, batch-to-batch consistency)